Mr. Ravi Kumar, CEO – India
Fertin Pharma A/S is pleased with the completion and commissioning of their new Nicotine Chewing gum manufacturing facility at Goa, India. The facility received approval from the Directorate of Food and Drugs Administration, Goa for manufacture of Nicotine Polacrilex Gum USP 2mg and 4 mg.
The 2200 sq mtr, state-of-the-art facility features a dedicated Production area, Quality Control Lab and a Microbiology Lab for the manufacture and testing of medicated chewing gum in compliance with cGMP. The Indian facility will supply products to the domestic market with future plans for export to emerging markets.
The commissioning of the facility has been completed in July 2015 and is due to commence commercial manufacturing by Dec 2015.